International Congress of the European Haematology Association Conference in Frankfurt Germany June 2023
22 June 2023International Congress of the European Haematology Association Conference in Frankfurt, Germany – 8th-11th June 2023
With more than 12,000 delegates a year, this conference is the leading meeting place for haematologists in all fields of this speciality in Europe and beyond. The focus for the CTR attendees, (myself, Joanna Canham and Oliver Cumming) was on acute myeloid leukaemia (AML) sessions, which included oral and poster presentations about the Cardiff University-Sponsored AML trials.
These presentations reflect many years of hard work by the trial teams, not least those named as authors below.
On Friday 9th, the AML sessions included oral presentations of AML18 (quizartinib experience, presented by Professor Steven Knapper) and AML19 (FLAG-Ida, presented by Professor Nigel Russell).
Results from the trials, which are supported by the NCRI AML working group, have always been held in high regard internationally, and the results were very well-received – the midotarg presentation forms the backbone of a new trial funding application, and the Quizartinib data is already of interest to our pharma collaborator.
The poster sessions throughout the conference included further presentation of data from AML19 (midotarg follow-up, Cumming, Wilhelm-Benartzi, Batten, Hinson, Canham) and posters below.
We expect these posters to progress to equally impactful publications as the poster presentations – in particular, the abstract based on molecular monitoring which included a dedication to the late (great) Professor David Grimwade.
As ever with conference attendance, the main business was undertaken between meetings, over coffee or evening dinner, dashing between sessions or, most challenging of all, a breakfast symposium. Jo and I were part of a number of promising meetings with pharma companies and international collaborators from Italy, Germany, France, Hong Kong, the US and across the UK. My personal highlight of the conference was a patient advocacy session where an Italian patient representative reminded us all that “I am not my disease, I am me”! His impassioned reference to understanding and communicating the ‘side-effects’ on a patient’s life rather than just drug-related toxicities was particularly poignant, and thought-provoking.
So, all in all, a very successful conference. As with most international conferences the time in (often) a new city is book-ended by a very early start and excited fatigue, and a very late finish with a sense of being dipped in coffee for 4 days. And then straight back to tackling the pile-up of emails the next day.
We will ‘go again’ though – and the CTR blood cancer group will no doubt be in a strong position to support key presentations at the American Society of Haematology conference in San Diego in December.
- Blog by Ian Thomas
- September 2024
- July 2024
- June 2024
- May 2024
- April 2024
- March 2024
- December 2023
- November 2023
- September 2023
- July 2023
- June 2023
- April 2023
- March 2023
- February 2023
- December 2022
- November 2022
- October 2022
- September 2022
- August 2022
- July 2022
- June 2022
- May 2022
- April 2022
- March 2022
- February 2022
- January 2022
- November 2021
- September 2021
- July 2021
- June 2021
- May 2021
- March 2021
- February 2021
- December 2020
- November 2020
- September 2020
- August 2020
- July 2020
- January 2020
- December 2019
- October 2019
- September 2019
- July 2019
- June 2019
- May 2019
- April 2019
- February 2019
- December 2018
- November 2018
- October 2018
- September 2018
- August 2018
- July 2018
- June 2018
- May 2018
- April 2018
- March 2018
- December 2017
- October 2017
- August 2017
- July 2017
- June 2017
- May 2017
- April 2017
- March 2017
- February 2017
- January 2017
- December 2016
- October 2016
- August 2016
- June 2016
- April 2016
- March 2016
- February 2016